CYNOMEL

This brand name is authorized in Estonia, France, Malta, Mexico.

Active ingredients

The drug CYNOMEL contains one active pharmaceutical ingredient (API):

1
UNII GCA9VV7D2N - LIOTHYRONINE SODIUM
 

Liothyronine sodium is a naturally occurring thyroid hormone. The biological action of liothyronine sodium is quantitatively similar to that of levothyroxine sodium.
 
Read more about Liothyronine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
H03AA02 Liothyronine sodium H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03A Thyroid preparations → H03AA Thyroid hormones
Discover more medicines within H03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1758258
FR Base de données publique des médicaments 67353712
MT Medicines Authority AA565/30202
MX Comisión Federal para la Protección contra Riesgos Sanitarios 48740

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈